Gwen Ambler Selected Research

IOWH-032

11/2021

A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gwen Ambler Research Topics

Disease

4	Pneumonia (Pneumonitis) 08/2019 - 01/2016
3	Infections 11/2021 - 01/2013
1	Cholera 11/2021
1	Diarrhea 11/2021
1	Neoplasms (Cancer) 01/2021
1	Glucosephosphate Dehydrogenase Deficiency 01/2021
1	Vivax Malaria 01/2021
1	Malaria 09/2018
1	Hypoxia (Hypoxemia) 01/2016
1	Tetanus 01/2013
1	Whooping Cough (Pertussis) 01/2013
1	Diphtheria 01/2013

Drug/Important Bio-Agent (IBA)

3	Anti-Bacterial Agents (Antibiotics)IBA 11/2021 - 01/2016
2	Amoxicillin (Wymox)FDA LinkGeneric 09/2018 - 01/2016
1	IOWH-032IBA 11/2021
1	Chloride Channels (Chloride Channel)IBA 11/2021
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 11/2021
1	rasburicase (Elitek)FDA Link 01/2021
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2021
1	boldenone undecylenate (Equipoise)IBA 08/2019
1	TabletsIBA 09/2018
1	Indicators and Reagents (Reagents)IBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2014
1	VaccinesIBA 01/2013
1	Complement System Proteins (Complement)IBA 01/2013

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2013
1	Duration of Therapy 09/2018